Anti-asthma simplified herbal medicine intervention-induced long-lasting tolerance to allergen exposure in an asthma model is interferon-g, but not transforming growth factor-β dependent

Clinical and Experimental Allergy

Volumn 40, Issue 11, 2010, Pages 1678-1688

  Srivastava, K ^a   Zhang, T ^a   Yang, N ^a   Sampson, H ^a   Li, X M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic asthma; IFN ; IgE; Mice; Th2 cytokines; Traditional Chinese medicine

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; HERBACEOUS AGENT; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CYTOKINE PRODUCTION; EXPOSURE; FEMALE; HERBAL MEDICINE; HISTOPATHOLOGY; IMMUNOGLOBULIN PRODUCTION; LUNG FUNCTION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SPLEEN CELL; TH2 CELL;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIBODIES; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FEMALE; IMMUNOGLOBULIN E; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; PNEUMONIA; PULMONARY EOSINOPHILIA; TH2 CELLS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 78649403280     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03545.x     Document Type: Article

References (50)

1. Braman SS. The global burden of asthma. Chest 2006; 130:4S-12S.
2. Lemanske RFJ. A review of the current guidelines for allergic rhinitis and asthma. J Allergy Clin Immunol 1998; 101:S392-6.
3. Hall IP. The beta-agonist controversy revisited. Lancet 2004; 363:183-4.
4. Sheth A, Reddymasu S, Jackson R. Worsening of asthma with systemic corticosteroids. J Gen Intern Med 2005; 21:C11-3.
5. Guilbert TW, Morgan WJ, Zeiger RS et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354:1985-97.
6. Aun MV, Ribeiro MR, Costa Garcia CL, Agondi RC, Kalil J, Giavina-Bianchi P. Esophageal candidiasis - an adverse effect of inhaled corticosteroids therapy. J Asthma 2009; 46:399-401.
7. Zora JA, Zimmerman D, Carey TL, O'Connell EJ, Yunginger JW. Hypothalamic-pituitary-adrenal axis suppression after shortterm, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986; 77:9-13.
8. Saini SS, MacGlashan DW, Sterbinsky SA et al. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. J Immunol 1999; 162:5624-30.
9. Papadopoulos NG, Philip G, Giezek H, Watkins M, Smugar SS, Polos PG. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity. J Asthma 2009; 46:413-20.
10. Early communication about an ongoing safety review of omalizumab (marketed as Xolair). Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm172218.htm (accessed 16 July 2009). FDA. Consum. 9 A.D.
11. Holbrook JT, Harik-Khan R. Montelukast and emotional wellbeing as a marker for depression: results from 3 randomized, double-masked clinical trials. J Allergy Clin Immunol 2008; 122:828-9.
12. Li XM. Complementary and alternative medicine in pediatric allergic disorders. Curr Opin Allergy Clin Immunol 2009; 9: 161-7.
13. Zhang T, Srivastava K, Wen M-C. et al. Pharmacology and immunological actions of a herbal medicine, ASHMITM on allergic asthma. Phytother Res 2009; DOI: 10.1002/ptr.3077.
14. Jayaprakasam B, Doddaga S, Wang R, Holmes D, Goldfarb J, Li XM. Licorice flavonoids inhibit eotaxin-1 secretion by human fetal lung fibroblasts in vitro. J Agric Food Chem 2009; 57:820-5.
15. Wen MC, Wei CH, Hu ZQ et al. Efficacy and tolerability of antiasthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol 2005; 116:517-24.
16. Kelly-Pieper K, Patil SP, Busse P et al. Safety and tolerability of an antiasthma herbal formula (ASHMITM) in adult asthmatics: a randomized, double-blinded, placebo-controlled, dose escalation phase I study. J Altern Complement Med 2009; 15: 735-43.
17. Xiu SY. The experimental method of pharmacology. Beijing: The People's Public Health Publisher, 1986.
18. Li XM, Huang CK, Zhang TF et al. The Chinese herbal medicine formula MSSM-002 suppresses allergic airway hyperreactivity and modulates TH1/TH2 responses in a murine model of allergic asthma. J Allergy Clin Immunol 2000; 106:660-8.
19. Busse PJ, Zhang TF, Srivastava K, Schofield B, Li XM. Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and - challenged mice. Clin Exp Allergy 2007; 37:1392-403.
20. Li XM, Schofield BH, Wang QF, Kim KH, Huang SK. Induction of pulmonary allergic responses by antigen-specific Th2 cells. J Immunol 1998; 160:1378-84.
21. Lim DH, Cho JY, Song DJ, Lee SY, Miller M, Broide DH. PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am J Physiol Lung Cell Mol Physiol 2009; 296:L210-9.
22. Srivastava K, Teper AA, Zhang TF et al. Immunomodulatory effect of the anti-asthma Chinese herbal formula, MSSM-002 on Th2 cells. J Allergy Clin Immunol 2004; 113:268-76.
23. Castro M, Bloch SR, Jenkerson MV et al. Asthma exacerbations after glucocorticoid withdrawal reflects T cell recruitment to the airway. Am J Respir Crit Care Med 2004; 169:842-9.
24. Wiley RE, Cwiartka M, Alvarez D et al. Transient corticosteroid treatment permanently amplifies the Th2 response in a murine model of asthma. J Immunol 2004; 172:4995-5005.
25. Nials AT, Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech 2008; 1:213-20.
26. Epstein MM. Do mouse models of allergic asthma mimic clinical disease? Int Arch Allergy Immunol 2004; 133:84-100.
27. Mathur M, Herrmann K, Li X. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am J Respir Crit Care Med 1999; 159:580-7.
28. Rogerio AP, Kanashiro A, Fontanari C et al. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm Res 2007; 56:402-8.
29. + T-cell depletion on bronchial hyper-responsiveness and inflammation in sensitized and allergen-exposed Brown-Norway rats. Immunology 1999; 96:416-23.
30. + T cells. J Allergy Clin Immunol 2009; 123:443-51.
31. + long-lived memory T cells in an allergy model. J Allergy Clin Immunol 2008; 121:992-9.
32. Hachem P, Lisbonne M, Michel ML et al. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma. Eur J Immunol 2005; 35:2793-802.
33. Chakir H, Wang H, Lefebvre DE, Webb J, Scott FW. T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. J Immunol Methods 2003; 278:157-69.
34. Delayre-Orthez C, Becker J, Auwerx J, Frossard N, Pons F. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate. Eur J Pharmacol 2008; 581:177-84.
35. Chang YH, Yang JS, Yang JL et al. Gandoderma lucidum extract promotes immune responses in normal BALB/c mice in vivo. In Vivo 2009; 23:755-9.
36. Lin YL, Liang YC, Lee SS, Chiang BL. Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. J Leukoc Biol 2005; 78:533-43.
37. Lin ZB. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 2005; 99:144-53.
38. 1 regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 2008; 122:617-24.
39. Salib RJ, Howarth PH. Transforming growth factor-beta in allergic inflammatory disease of the upper airways: friend or foe? Clin Exp Allergy 2009; 39:1128-35.
40. Goplen N, Karim MZ, Liang Q et al. Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma. J Allergy Clin Immunol 2009; 123:925-32.
41. + T cells. Clin Exp Allergy 2007; 37:1374-85.
42. Polte T, Foell J, Werner C et al. CD137-mediated immunotherapy for allergic asthma. J Clin Invest 2006; 116:1025-36.
43. Daniel C, Repa A, Wild C et al. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 2006; 61:812-9.
44. Korf JE, Pynaert G, Tournoy K et al. Macrophage reprogramming by mycolic acid promotes a tolerogenic response in experimental asthma. Am J Respir Crit Care Med 2006; 174:152-60.
45. Guerra S, Lohman IC, Halonen M, Martinez FD, Wright AL. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med 2004; 169:70-6.
46. Stern DA, Guerra S, Halonen M, Wright AL, Martinez FD. Low IFN-gamma production in the first year of life as a predictor of wheeze during childhood. J Allergy Clin Immunol 2007; 120:835-41.
47. Boguniewicz M, Martin RJ, Martin D et al. The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol 1995; 95:133-5.
48. Gauvreau GM, Hessel EM, Boulet LP, Coffman RL, O'Byrne PM. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med 2006; 174:15-20.
49. Choi IS, Koh YI. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann Allergy Asthma Immunol 2002; 88:584-91.
50. Patil SP, Ji WJ, Singha A et al. In vitro immunomodulatory effect of ASHMI (anti-asthma herbal medicine intervention) on PBMCs from asthmatics. J Allergy Clin Immunol 2010; 125:AB198.